CURI vs GAIA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

CURI

47.7
AI Score
VS
CURI Wins

GAIA

32.6
AI Score

Investment Advisor Scores

CURI

48score
Recommendation
HOLD

GAIA

33score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI GAIA Winner
Forward P/E 8.4175 138.8889 CURI
PEG Ratio 0 1.2274 Tie
Revenue Growth 22.3% -5.3% CURI
Earnings Growth 1400.0% -87.8% CURI
Tradestie Score 47.7/100 32.6/100 CURI
Profit Margin 0.0% -6.1% CURI
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL CURI

Relative Price Performance (Last 90 Days)

CURI 1M: -5.0% · 3M: +2.3% GAIA 1M: +11.6% · 3M: -47.1%

Current Technical Phase

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.7 · Price: $2.66

GAIA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.9%), weak momentum, RSI 34

RSI (14): 34.2 · Price: $1.35

Fundamentals Snapshot

Metric CURI GAIA
Market Cap
Forward P/E 8.6 -3.5
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% -0.1%
Gross Margin 0.6% 0.9%
Operating Margin 0.4% -0.1%
EPS -0.01 -0.24
Dividend Yield 0.13%

Frequently Asked Questions

Based on our detailed analysis, CURI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.